Saturday, October 31, 2026

Ethereum On Bullish Momentum: 0.56% Up In The Last 6 Hours

ViaNews Editorial Team

December 28, 2020

Ethereum On Bullish Momentum: 0.56% Up In The Last 6 Hours

Ethereum is currently on bullish momentum. At 10:05 EST on Monday, 28 December, Ethereum is at $736.98 and up by 0.56% in the last 6 hours.

Ethereum Range

Over the last six hours, Ethereum's higher value was $736.98 and the lower value was $723.95.

Over the last twelve hours, Ethereum's higher value was $736.98 and the lower value was $701.66.

Regarding Ethereum's daily lows, it's 8.836% up from its trailing 24-hour low of $677.15

In relation to Ethereum's yearly highs and lows, it's 674.301% up from its 52-week low and 0.06% down from its 52-week high.

Volatility

Ethereum's last day and last week average volatility is a positive 7.36% and a positive 4.97%, respectively. Ethereum's high and low amplitude percentage in the last week was 8.97%.

News about Bitcoin

Bitcoin surges to fresh record high and looks set to break the $25,000 level: 'merry bitmas'. According to Business Insider on Fri Dec 25, "However, Bitcoin investors - known for their unquenchable optimism - think this is just the start.", "Known as the leading cryptocurrency, Bitcoin has been a surprise success during the pandemic, quickly becoming a competitor to gold in some portfolios."

Bitcoin miners in nordic region get a boost from cheap power. According to Bloomberg Quint on Sun Dec 27, "Having coin flowing from the Nordic region helps reduce the political risk profile of Bitcoin.", ""There is a very important strategic shift away from mining in China to mining in western countries like Sweden as Bitcoin investors become more public and want more stability and critical safety," said Salter at Genesis. "

Bitcoin faces regulatory scrutiny after record-breaking rally. According to Bloomberg Quint on Sun Dec 27, "Janet Yellen, who's been nominated to serve as Treasury secretary in Biden's administration, has in recent years cautioned investors over Bitcoin, saying it was a "highly speculative asset" and "not a stable store of value." A representative didn't immediately return a request seeking comment.", "Clayton's exit from the regulator is welcome news for crypto fans who saw him take a hard line over the years, suing to halt initial coin offerings, rejecting applications for Bitcoin exchange-traded funds and launching a last-minute lawsuit against Ripple Labs Inc. Gensler, who served as a Commodity Futures Trading Commission chairman during the Obama administration, is a senior advisor to the MIT Media Lab Digital Currency Initiative and teaches about blockchain technology and digital currencies."

Bitcoin on longest winning run since 2019 after hitting record. According to Bloomberg Quint on Mon Dec 28, "Bitcoin has divided opinion as its price more than tripled in 2020 amid a worsening pandemic. ", "Bitcoin climbed as much as 3.6% on Monday and was trading at about $27,150 as of 1 p.m. in Tokyo. "

ViaNews Editorial Team

Via News Editorial Team delivers comprehensive financial news coverage and market analysis from journalists around the world. Our team specializes in data journalism and in-depth reporting on stock markets, business developments, and economic trends.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com